• 1
    Kittleson MD, Meurs KM, Munro MJ, et al. Familial hypertrophic cardiomyopathy in maine coon cats: An animal model of human disease. Circulation 1999;99:31723180.
  • 2
    Meurs KM, Sanchez X., David RM, et al. A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy. Hum Mol Genet. 2005; 14: 35873593.
  • 3
    Marian AJ, Salek L., Lutucuta S. Molecular genetics and pathogenesis of hypertrophic cardiomyopathy. Minerva Med. 2001; 92: 435451.
  • 4
    Van Driest SL, Ommen SR, Tajik AJ, et al. Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc 2005;80:463469.
  • 5
    Bright JM, Herrtage ME, Schneider JF. Pulsed Doppler assessment of left ventricular diastolic function in normal and cardiomyopathic cats. J Am Anim Hosp Assoc. 1999; 35: 285291.
  • 6
    Gavaghan BJ, Kittleson MD, Fisher KJ, et al. Quantification of left ventricular diastolic wall motion by Doppler tissue imaging in healthy cats and cats with cardiomyopathy. Am J Vet Res. 1999; 60: 14781486.
  • 7
    Sohn DW, Chai IH, Lee DJ, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol. 1997; 30: 474480.
  • 8
    Rajiv C., Vinereanu D., Fraser AG. Tissue Doppler imaging for the evaluation of patients with hypertrophic cardiomyopathy. Curr Opin Cardiol. 2004; 19: 430436.
  • 9
    Cardim N., Torres D., Morais H., et al. Tissue Doppler imaging in hypertrophic cardiomyopathy: impact of intraventricular obstruction on longitudinal left ventricular function. Rev Port Cardiol. 2002; 21: 271297.
  • 10
    Koffas H., Dukes-McEwan J., Corcoran BM, et al. Pulsed tissue Doppler imaging in normal cats and cats with hypertrophic cardiomyopathy. J Vet Intern Med 2006;20:6577.
  • 11
    de Boeck BW, Cramer MJ, Oh JK, et al. Spectral pulsed tissue Doppler imaging in diastole: a tool to increase our insight in and assessment of diastolic relaxation of the left ventricle. Am Heart J 2003;146:411419.
  • 12
    Schober KE, Fuentes VL, Bonagura JD. Comparison between invasive hemodynamic measurements and noninvasive assessment of left ventricular diastolic function by use of Doppler echocardiography in healthy anesthetized cats. Am J Vet Res 2003;64:93103.
  • 13
    Van Driest SL, Vasile VC, Ommen SR, et al. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;44:19031910.
  • 14
    Nagueh SF, McFalls J., Meyer D., et al. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation 2003;108:395398.
  • 15
    Nagueh SF, Kopelen HA, Lim DS, et al. Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation 2000;102:13461350.
  • 16
    Meurs KM, Kittleson M., Spangler E., et al. Nine polymorphisms within the head and hinge region of the feline cardiac beta-myosin heavy chain gene. Anim Genet 2000;31:231.
  • 17
    Rozen S., Skaletsky H. Bioinformatics, methods, and protocols. In: KrawetzS., MisenerS., eds. Methods in Molecular Biology. Totowa , NJ : Humana Press 2000: 365386.
  • 18
    MacDonald KA, Kittleson MD, Garcia-Nolen T., et al. Tissue Doppler imaging and gradient echo cardiac magnetic resonance imaging in normal cats and cats with hypertrophic cardiomyopathy. J Vet Intern Med 2006, In press.
  • 19
    Nagueh SF, Bachinski LL, Meyer D., et al. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 2001;104:128130.
  • 20
    Ho CY, Sweitzer NK, McDonough B., et al. Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 2002; 105: 29922997.
  • 21
    Marian AJ, Zhao G., Seta Y., et al. Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility. Circ Res 1997;81:7685.
  • 22
    Rust EM, Albayya FP, Metzger JM. Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins. J Clin Invest 1999;103:14591467.
  • 23
    Harris SP, Bartley CR, Hacker TA, et al. Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice. Circ Res. 2002; 90: 594601.
  • 24
    Weisberg A., Winegrad S. Alteration of myosin cross bridges by phosphorylation of myosin-binding protein C in cardiac muscle. Proc Natl Acad Sci USA 1996;93:89999003.
  • 25
    Calaghan SC, Trinick J., Knight PJ, White E. A role for Cprotein in the regulation of contraction and intracellular Ca2+ in intact rat ventricular myocytes. J Physiol 2000;528:151156.
  • 26
    Witt CC, Gerull B., Davies MJ, et al. Hypercontractile properties of cardiac muscle fibers in a knock-in mouse model of cardiac myosin-binding protein-C. J Biol Chem 2001;276:53535359.